tiprankstipranks
Trending News
More News >
RemeGen Co. Ltd. Class H (HK:9995)
:9995

Compare RemeGen Co. Ltd. Class H (9995) vs. Competitors

Compare
6 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
RemeGen Co. Ltd. Class H
HK$94.65
HK$57.70B
-50.14
680.94%
4 Buy
3 Hold
0 Sell
Moderate Buy
Genscript Biotech
HK$14.33
HK$31.17B
53.26%
3 Buy
0 Hold
0 Sell
Strong Buy
Zai Lab Ltd
HK$22.18
HK$16.21B
-9.55
-25.21%
5 Buy
2 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$25.16
HK$40.05B
-24.53
134.70%
0 Buy
1 Hold
1 Sell
Moderate Sell
Simcere Pharmaceutical Group Limited
HK$12.15
HK$31.54B
31.48
81.89%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$58.60
HK$36.41B
40.91
183.90%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:9995
RemeGen Co. Ltd. Class H
94.65
82.57
683.53%
HK:1548
Genscript Biotech
14.33
5.33
59.22%
HK:9688
Zai Lab Ltd
14.51
-4.85
-25.05%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
25.16
14.68
140.08%
HK:2096
Simcere Pharmaceutical Group Limited
12.15
5.73
89.25%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
67.00
44.50
197.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts